Skip to main content
Erschienen in: Wiener klinische Wochenschrift 21-22/2015

01.11.2015 | original article

Prognostic significance of transaminases after acute ST-elevation myocardial infarction: insights from a cardiac magnetic resonance study

verfasst von: Sebastian J. Reinstadler, MD, Martin Reindl, MD, Hans-Josef Feistritzer, MD, Gert Klug, MD, Agnes Mayr, MD, Markus Kofler, MD, Alexander Minh-Duc Tu, MD, Luc Huybrechts, MD, Johannes Mair, MD, Wolfgang-Michael Franz, MD, Bernhard Metzler, MD, MSc

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 21-22/2015

Einloggen, um Zugang zu erhalten

Summary

Background

In patients with ST-elevation myocardial infarction (STEMI), the relationship between transaminases and myocardial damage detected by cardiac magnetic resonance (CMR) imaging is unknown and the prognostic value incompletely investigated.

Materials and methods

CMR imaging was performed in 167 STEMI patients 2.3 [1.6–3.9] days after primary percutaneous coronary intervention (PPCI). Blood samples for transaminase measurement (aspartate transaminase (AST) and alanine transaminase (ALT)) were obtained serially from day 1 to day 4 after PPCI. Patients were followed for major adverse cardiac events (MACE) for 2.7 [1.1–3.3] years.

Results

Admission and peak concentrations of AST and ALT were significantly associated with ejection fraction (p < 0.001), infarct size (p < 0.001), and the presence of microvascular obstruction (p < 0.01). Peak values of both transaminases showed a stronger correlation with CMR parameters than admission values (all p < 0.05). In Kaplan–Meier analysis, a high peak AST or high peak ALT was associated with reduced MACE-free survival (both p < 0.01), whereas admission values were not (both p > 0.05). Peak AST (hazard ratio (HR): 4.93 [1.70–14.32], p = 0.003) and peak ALT (HR: 5.67 [1.94–16.56], p = 0.002) were independent predictors of MACE after adjusting for clinical risk factors.

Conclusions

Transaminases measured in the acute phase after PPCI for STEMI are associated with systolic dysfunction, more extensive myocardial necrosis and microvascular injury with subsequent prognostic information on MACE at long-term follow-up.
Literatur
1.
Zurück zum Zitat Jernberg T, Johanson P, Held C, Svennblad B, Lindback J, Wallentin L, Swedeheart/Riks HIA. Association between adoption of evidence-based treatment and survival for patients with ST-elevation myocardial infarction. JAMA. 2011;305:1677–84.CrossRefPubMed Jernberg T, Johanson P, Held C, Svennblad B, Lindback J, Wallentin L, Swedeheart/Riks HIA. Association between adoption of evidence-based treatment and survival for patients with ST-elevation myocardial infarction. JAMA. 2011;305:1677–84.CrossRefPubMed
2.
Zurück zum Zitat Steg PG, James SK, Atar D, Badano LP, Blomstrom-Lundqvist C, Borger MA, Di Mario C, Dickstein K, Ducrocq G, Fernandez-Aviles F, Gershlick AH, Giannuzzi P, Halvorsen S, Huber K, Juni P, Kastrati A, Knuuti J, Lenzen MJ, Mahaffey KW, Valgimigli M, van ’t Hoff A, Widimsky P, Zahger D. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33:2569–619.CrossRefPubMed Steg PG, James SK, Atar D, Badano LP, Blomstrom-Lundqvist C, Borger MA, Di Mario C, Dickstein K, Ducrocq G, Fernandez-Aviles F, Gershlick AH, Giannuzzi P, Halvorsen S, Huber K, Juni P, Kastrati A, Knuuti J, Lenzen MJ, Mahaffey KW, Valgimigli M, van ’t Hoff A, Widimsky P, Zahger D. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33:2569–619.CrossRefPubMed
3.
4.
Zurück zum Zitat Chinsky M, Shmagranoff GL, Sherry S. Serum transaminase activity; observations in a large group of patients. J Lab Clin Med. 1956;47:108–18.PubMed Chinsky M, Shmagranoff GL, Sherry S. Serum transaminase activity; observations in a large group of patients. J Lab Clin Med. 1956;47:108–18.PubMed
5.
Zurück zum Zitat Lofthus DM, Stevens SR, Armstrong PW, Granger CB, Mahaffey KW. Pattern of liver enzyme elevations in acute ST-elevation myocardial infarction. Coron Artery Dis. 2012;23:22–30.CrossRefPubMed Lofthus DM, Stevens SR, Armstrong PW, Granger CB, Mahaffey KW. Pattern of liver enzyme elevations in acute ST-elevation myocardial infarction. Coron Artery Dis. 2012;23:22–30.CrossRefPubMed
6.
Zurück zum Zitat Lazzeri C, Valente S, Tarquini R, Chiostri M, Picariello C, Gensini GF. Prognostic values of admission transaminases in ST-elevation myocardial infarction submitted to primary angioplasty. Med Sci Monit. 2010;16:567–74. Lazzeri C, Valente S, Tarquini R, Chiostri M, Picariello C, Gensini GF. Prognostic values of admission transaminases in ST-elevation myocardial infarction submitted to primary angioplasty. Med Sci Monit. 2010;16:567–74.
7.
Zurück zum Zitat Moon J, Kang W, Oh PC, Seo SY, Lee K, Han SH, Ahn T, Shin E. Serum transaminase determined in the emergency room predicts outcomes in patients with acute ST-segment elevation myocardial infarction who undergo primary percutaneous coronary intervention. Int J Cardiol. 2014;177:442–7.CrossRefPubMed Moon J, Kang W, Oh PC, Seo SY, Lee K, Han SH, Ahn T, Shin E. Serum transaminase determined in the emergency room predicts outcomes in patients with acute ST-segment elevation myocardial infarction who undergo primary percutaneous coronary intervention. Int J Cardiol. 2014;177:442–7.CrossRefPubMed
8.
Zurück zum Zitat Lazzeri C, Valente S, Boddi M, Mecarocci V, Chiostri M, Gensini GF. Clinical and prognostic significance of increased liver enzymes in ST-elevation myocardial infarction. Int J Cardiol. 2014;177:543–4.CrossRefPubMed Lazzeri C, Valente S, Boddi M, Mecarocci V, Chiostri M, Gensini GF. Clinical and prognostic significance of increased liver enzymes in ST-elevation myocardial infarction. Int J Cardiol. 2014;177:543–4.CrossRefPubMed
9.
Zurück zum Zitat Klug G, Mayr A, Schenk S, Esterhammer R, Schocke M, Nocker M, Jaschke W, Pachinger O, Metzler B. Prognostic value at 5 years of microvascular obstruction after acute myocardial infarction assessed by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2012;14:46.CrossRefPubMedPubMedCentral Klug G, Mayr A, Schenk S, Esterhammer R, Schocke M, Nocker M, Jaschke W, Pachinger O, Metzler B. Prognostic value at 5 years of microvascular obstruction after acute myocardial infarction assessed by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2012;14:46.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Eitel I, de Waha S, Wohrle J, Fuernau G, Lurz P, Pauschinger M, Desch S, Schuler G, Thiele H. Comprehensive prognosis assessment by CMR imaging after ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2014;64:1217–26.CrossRefPubMed Eitel I, de Waha S, Wohrle J, Fuernau G, Lurz P, Pauschinger M, Desch S, Schuler G, Thiele H. Comprehensive prognosis assessment by CMR imaging after ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2014;64:1217–26.CrossRefPubMed
11.
Zurück zum Zitat de Waha S, Desch S, Eitel I, Fuernau G, Lurz P, Leuschner A, Grothoff M, Gutberlet M, Schuler G, Thiele H. Relationship and prognostic value of microvascular obstruction and infarct size in ST-elevation myocardial infarction as visualized by magnetic resonance imaging. Clin Res Cardiol. 2012;101:487–95.CrossRefPubMed de Waha S, Desch S, Eitel I, Fuernau G, Lurz P, Leuschner A, Grothoff M, Gutberlet M, Schuler G, Thiele H. Relationship and prognostic value of microvascular obstruction and infarct size in ST-elevation myocardial infarction as visualized by magnetic resonance imaging. Clin Res Cardiol. 2012;101:487–95.CrossRefPubMed
12.
Zurück zum Zitat Klug G, Metzler B. Assessing myocardial recovery following ST-segment elevation myocardial infarction: short- and long-term perspectives using cardiovascular magnetic resonance. Expert Rev Cardiovasc Ther. 2013;11:203–19.CrossRefPubMed Klug G, Metzler B. Assessing myocardial recovery following ST-segment elevation myocardial infarction: short- and long-term perspectives using cardiovascular magnetic resonance. Expert Rev Cardiovasc Ther. 2013;11:203–19.CrossRefPubMed
13.
Zurück zum Zitat Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined–a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J. 2000;21:1502–13. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined–a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J. 2000;21:1502–13.
14.
Zurück zum Zitat Reinstadler SJ, Klug G, Feistritzer HJ, Mayr A, Harrasser B, Mair J, Bader K, Streil K, Hammerer-Lercher A, Esterhammer R, Metzler B. Association of copeptin with myocardial infarct size and myocardial function after ST segment elevation myocardial infarction. Heart. 2013;99:1525–9.CrossRefPubMed Reinstadler SJ, Klug G, Feistritzer HJ, Mayr A, Harrasser B, Mair J, Bader K, Streil K, Hammerer-Lercher A, Esterhammer R, Metzler B. Association of copeptin with myocardial infarct size and myocardial function after ST segment elevation myocardial infarction. Heart. 2013;99:1525–9.CrossRefPubMed
15.
Zurück zum Zitat Klug G, Trieb T, Schocke M, Nocker M, Skalla E, Mayr A, Nowosielski M, Pedarnig K, Bartel T, Moes N, Pachinger O, Metzler B. Quantification of regional functional improvement of infarcted myocardium after primary PTCA by contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging. 2009;29:298–304.CrossRefPubMed Klug G, Trieb T, Schocke M, Nocker M, Skalla E, Mayr A, Nowosielski M, Pedarnig K, Bartel T, Moes N, Pachinger O, Metzler B. Quantification of regional functional improvement of infarcted myocardium after primary PTCA by contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging. 2009;29:298–304.CrossRefPubMed
16.
Zurück zum Zitat Bondarenko O, Beek AM, Hofman MB, Kuhl HP, Twisk JW, van Dockum WG, Visser CA, van Rossum AC. Standardizing the definition of hyperenhancement in the quantitative assessment of infarct size and myocardial viability using delayed contrast-enhanced CMR. J Cardiovasc Magn Reson. 2005;7:481–5.CrossRefPubMed Bondarenko O, Beek AM, Hofman MB, Kuhl HP, Twisk JW, van Dockum WG, Visser CA, van Rossum AC. Standardizing the definition of hyperenhancement in the quantitative assessment of infarct size and myocardial viability using delayed contrast-enhanced CMR. J Cardiovasc Magn Reson. 2005;7:481–5.CrossRefPubMed
17.
Zurück zum Zitat Mayr A, Klug G, Schocke M, Trieb T, Mair J, Pedarnig K, Pachinger O, Jaschke W, Metzler B. Late microvascular obstruction after acute myocardial infarction: relation with cardiac and inflammatory markers. Int J Cardiol. 2012;157:391–6.CrossRefPubMed Mayr A, Klug G, Schocke M, Trieb T, Mair J, Pedarnig K, Pachinger O, Jaschke W, Metzler B. Late microvascular obstruction after acute myocardial infarction: relation with cardiac and inflammatory markers. Int J Cardiol. 2012;157:391–6.CrossRefPubMed
18.
Zurück zum Zitat Reinstadler SJ, Klug G, Feistritzer HJ, Mayr A, Bader K, Mair J, Esterhammer R, Schocke M, Metzler B. Relation of plasma adiponectin levels and aortic stiffness after acute ST-segment elevation myocardial infarction. Eur Heart J Acute Cardiovasc Care. 2014;3:10–7.CrossRefPubMedPubMedCentral Reinstadler SJ, Klug G, Feistritzer HJ, Mayr A, Bader K, Mair J, Esterhammer R, Schocke M, Metzler B. Relation of plasma adiponectin levels and aortic stiffness after acute ST-segment elevation myocardial infarction. Eur Heart J Acute Cardiovasc Care. 2014;3:10–7.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Hosmer DW, Lemeshow S. Applied survival analysis: regression modeling of time to event data. New York: Wiley; 1999. Hosmer DW, Lemeshow S. Applied survival analysis: regression modeling of time to event data. New York: Wiley; 1999.
21.
Zurück zum Zitat Giesen PL, Peltenburg HG, de Zwaan C, Janson PC, Flendrig JG, Hermens WT. Greater than expected alanine aminotransferase activities in plasma and in hearts of patients with acute myocardial infarction. Clin Chem. 1989;35:279–83.PubMed Giesen PL, Peltenburg HG, de Zwaan C, Janson PC, Flendrig JG, Hermens WT. Greater than expected alanine aminotransferase activities in plasma and in hearts of patients with acute myocardial infarction. Clin Chem. 1989;35:279–83.PubMed
22.
Zurück zum Zitat Lindblom P, Rafter I, Copley C, Andersson U, Hedberg JJ, Berg AL, Samuelsson A, Hellmold H, Cotgreave I, Glinghammar B. Isoforms of alanine aminotransferases in human tissues and serum–differential tissue expression using novel antibodies. Arch Biochem Biophys. 2007;466:66–77.CrossRefPubMed Lindblom P, Rafter I, Copley C, Andersson U, Hedberg JJ, Berg AL, Samuelsson A, Hellmold H, Cotgreave I, Glinghammar B. Isoforms of alanine aminotransferases in human tissues and serum–differential tissue expression using novel antibodies. Arch Biochem Biophys. 2007;466:66–77.CrossRefPubMed
Metadaten
Titel
Prognostic significance of transaminases after acute ST-elevation myocardial infarction: insights from a cardiac magnetic resonance study
verfasst von
Sebastian J. Reinstadler, MD
Martin Reindl, MD
Hans-Josef Feistritzer, MD
Gert Klug, MD
Agnes Mayr, MD
Markus Kofler, MD
Alexander Minh-Duc Tu, MD
Luc Huybrechts, MD
Johannes Mair, MD
Wolfgang-Michael Franz, MD
Bernhard Metzler, MD, MSc
Publikationsdatum
01.11.2015
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 21-22/2015
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-015-0868-6

Weitere Artikel der Ausgabe 21-22/2015

Wiener klinische Wochenschrift 21-22/2015 Zur Ausgabe

MUW researcher of the month

MUW researcher of the month